Form D Worth Mentioning Today: Acufocus $74.92 million Fundraising. Jason Tester Submitted Oct 5 D Form

Biotechnology Acufocus, Inc. - Jason Tester

Acufocus Financing

Acufocus, Inc., Corporation just released form D regarding $74.92 million equity financing. This is a new filing. Acufocus was able to finance itself with $74.92 million. That is 100.00% of the financing round. The total private financing amount was $74.92 million. This form was filed on 2016-10-05. The reason for the financing was: unspecified.

Acufocus is based in California. The filler’s business is Biotechnology. The form D was filed by Jason Tester Chief Financial Officer and Secretary. The company was incorporated more than five years ago. The filler’s address is: 32 Discovery, Suite 200, Irvine, Ca, California, 92618-3161. Alan Waterhouse is the related person in the form and it has address: 32 Discovery, Suite 200, Irvine, Ca, California, 92618. Link to Acufocus Filing: 000114036116081947.

Analysis of Acufocus Offering

On average, firms in the Biotechnology sector, sell 73.77% of the total offering amount. Acufocus sold 100.00% of the offering. Could this mean that the trust in Acufocus is high? The average investment size for companies in the Biotechnology industry is $3.08 million. The total amount raised is 2,332.62% bigger than the average for companies in the Biotechnology sector. The minimum investment for this fundraising is set at $0. If you know more about the reasons for the fundraising, please comment below.

What is Form D? What It Is Used For

Form D disclosures could be used to track and understand better your competitors. The information in Form D is usually highly confidential for ventures and startups and they don’t like revealing it. This is because it reveals amount raised or planned to be raised as well as reasons for the financing. This could help competitors. Entrepreneurs usually want to keep their financing a ‘secret’ so they can stay in stealth mode for longer.

Why Fundraising Reporting Is Good For Acufocus Also

The Form D signed by Jason Tester might help Acufocus, Inc.’s sector. First, it helps potential customers feel more safe to deal with a firm that is well financed. The odds are higher that it will stay in the business. Second, this could attract other investors such as venture-capital firms, funds and angels. Third, positive PR effects could even bring leasing firms and venture lenders.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.

Related posts

Leave a Comment